| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Madrigal Pharmaceuticals, Inc. (MDGL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 452.2K | $241.87M | - | |
| Dir | 205.0K | $109.65M | - | |
| Dir | 200.0K | $106.99M | - | |
| CEO | 150.1K | $80.27M | - | |
| Dir | 29.7K | $15.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Kelley Shannon T | General Counsel | Sell | 415 | $335.00 | $139,025.00 | -5.4% | -13.0% | +35.9% | |
| Mar 3, 2025 | Dier Mardi70 | SVP And CFO | Sell | 1,961 | $324.96 | $637,248.06 | -11.8% | -13.0% | +35.9% | |
| Feb 28, 2025 | Waltermire Robert E.48 | Senior VP, Chief Pharma Dev. | Sell | 1,227 | $341.07 | $418,488.05 | -13.9% | -20.9% | +26.7% | |
| Feb 27, 2025 | Bate Kenneth | Director | Sale+OE | 20,000 | $356.44 | $7,128,758.96 | -16.3% | -19.3% | +28.8% | |
| Feb 27, 2025 | Daly James M | Director | Sale+OE | 15,470 | $347.45 | $5,375,125.55 | -41.8% | -19.3% | +28.8% | |
| Jan 24, 2025 | Huntsman Carole | Chief Commercial Officer | Sell | 347 | $335.24 | $116,328.28 | -3.2% | -2.5% | +46.4% | |
| Jan 24, 2025 | Sibold William John | President And CEO | Sell | 1,584 | $335.24 | $531,020.16 | -2.8% | -2.5% | +46.4% | |
| Jan 24, 2025 | Taub Rebecca | Pres., R&D, And CMO | Sell | 648 | $335.24 | $217,235.52 | -0.1% | -2.5% | +46.4% | |
| Jan 24, 2025 | Waltermire Robert E.48 | Senior VP, Chief Pharma Dev. | Sell | 103 | $335.24 | $34,529.72 | -2.0% | -2.5% | +46.4% | |
| Jan 17, 2025 | Kelley Shannon T | General Counsel | Sell | 277 | $273.41 | $75,734.57 | -3.5% | +2.7% | +70.8% |